Public procurement notice: Contract Notice
Published: 2019-09-12
Buyer: The Common Services Agency (more commonly known as NHS National Services Scotland) (‘NSS’)
Country: UK
Contract type: Supplies
Procedure: Open procedure
CPV classification: 33600000: Pharmaceutical products | 33661100
Estimated value: 3699032 GBP
Submission deadline: 2019-10-14
Award criteria: The most economic tender

Technical requirements: This procurement is for the supply of Sevoflurane and Isoflurane anaesthetic gas, including the supply of loaned vaporisers for the administration of Sevoflurane, to NHSScotland.
All entities constituted pursuant to the National Health Services (Scotland) Act 1978 and any integrated joint boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.
This lot is for the supply of Sevoflurane Anaesthetic Gas to NHSScotland, including the loan of vaporisers for the administration of Sevoflurane for the duration of the framework agreement.
This lot will be awarded as a ranked multi supplier framework. It is envisaged that a maximum of three (3) suppliers will be awarded to the lot.
All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any integrated joint boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.
All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.
Economic operators may be excluded from this competition if they are in breach of any of the situation referred to in Regulation 58 of the Public Contracts (Scotland) Regulations 2015.
(a) Potential framework participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation/EMEA marketing authorisation that has been approved by the MHRA for all goods tendered at the date of submission of the tender;
(b) potential framework participants must be able to demonstrate that vaporisers, cassettes and tubing comply with Medical Device Directive 93/42/EEC and carry the appropriate CE declaration of conformity;
(c) all tendered goods must comply with the MHRA best practice guidance on labelling and packaging and the National Patient Safety Agency (‘NPSA’) guidelines on packaging and labelling on pack design;
(d) the successful framework participant(s) and any subcontractor(s) must possess valid certification of BS EN ISO9001 or equivalent;
(e) potential framework participants must be included on the Health Facilities Scotland Register of Suppliers holding Master Indemnity Agreements (MIA) and must be able to provide an MIA (Scotland) agreement number.
(a) confirmation of existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by the MHRA for all tendered medicines at the date of submission of the tender should be included in the qualification envelope of the ITT under the technical and professional ability: quality control;
(b) confirmation that any products submitted and classed as medical devices carry a current and valid CE declaration of conformity, complying with Medical Device Directive 93/42/EEC at the date of submission of the tender should be included in the qualification envelope of the ITT under the technical and professional ability: quality control;
(c) confirmation that samples for tendered Goods will be supplied upon request to ensure compliance with the MHRA best practice guidance on labelling and packaging and the National Patient Safety Agency (‘NPSA’) guidelines on packaging and labelling on pack design. Confirmation of sample provision should be provided in the qualification envelope of the ITT under technical and professional ability: products;

Eligibility requirements: Economic operators may be excluded from this competition if they are in breach of any of the situation referred to in Regulation 58 of the Public Contracts (Scotland) Regulations 2015.

Award value: 3699032